The United Laboratories International Holdings Limited (HKG:3933)

Market Cap	22.95B +12.5%
Revenue (ttm)	15.45B +0.7%
Net Income	3.36B +5.3%
EPS	1.85 +5.3%
Shares Out	1.97B
PE Ratio	6.30
Forward PE	7.07
Dividend	0.63 (5.29%)
Ex-Dividend Date	Sep 25, 2025

Volume	2,277,000
Average Volume	10,177,625
Open	11.70
Previous Close	11.63
Day's Range	11.64 - 11.96
52-Week Range	11.02 - 17.98
Beta	0.12
RSI	43.16
Earnings Date	Mar 26, 2026

About HKG:3933

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 17,400
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3933

Financial Performance

In 2024, HKG:3933's revenue was 13.76 billion, an increase of 0.14% compared to the previous year's 13.74 billion. Earnings were 2.66 billion, a decrease of -1.54%.

Financial numbers in CNY